臓器チップ(Organ-on-a-Chip)市場 - 世界の産業規模、シェア、動向、機会、予測：種類別、提供内容別、材料タイプ別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

世界の臓器チップ(Organ-on-a-Chip)市場は、2024年には4億6,757万米ドルとなり、予測期間では2030年までCAGR 25.61%で目覚ましい成長を遂げると予測されています。

臓器チップは、人間の臓器を精巧に再現した人工臓器です。これらの最先端デバイスは、マルチチャンネル3Dマイクロ流体細胞培養技術を利用して、臓器の機能、プロセス、生理的反応を忠実に模倣します。ラボオンチップ（LOC）を細胞生物学と組み合わせることで、研究者たちは体外多細胞ヒトの新規モデルの作成に成功し、臓器特異的環境におけるヒト生理学の解析を可能にしています。

市場概要
予測期間	2026-2030
市場規模：2024年	4億6,757万米ドル
市場規模：2030年	18億400万米ドル
CAGR：2025年～2030年	25.61%
急成長セグメント	製薬・バイオテクノロジー企業
最大市場	北米

これらのチップは、血液や空気の流れを促進するように複雑に設計されたマイクロチャネルを特徴としており、肺、腸、脳、肝臓、心臓などの様々な臓器のシミュレーションを可能にします。マイクロチップには生きた細胞が配置され、絶え間ない灌流によって組織や臓器の機能を育みます。臓器チップテクノロジーは、シリコーン栄養、組織工学、マイクロ流体工学を独自に融合させたもので、この分野に革命を起こす可能性を秘めています。これらの進歩は、創薬や疾病治療における長年の課題への対応に大きな期待を抱かせ、医薬品開発調査における重要な要素となり、臓器チップ業界を前進させる。

主要市場促進要因

電子チップの小型化需要の高まり

主な市場課題

臓器チップデバイスの高コストによる懸念

主要市場動向

市場開発の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の臓器チップ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 種類別（肝臓、心臓、肺、腎臓、その他）
  • 提供内容別（製品、サービス）
  • 材料タイプ別（ポリマー、PDMS、ガラス、シリコン、その他）
  • 用途別（生理モデル開発、創薬、毒性調査、分子生物学、その他）
  • エンドユーザー別（製薬・バイオテクノロジー企業、学術・調査機関、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の臓器チップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の臓器チップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の臓器チップ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の臓器チップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの臓器チップ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の臓器チップ市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Altis Biosystems
• AxoSim Inc.
• BiomimX SRL
• Emulate Inc.
• Hesperos
• Allevi Inc.
• InSphero AG
• MIMETAS BV
• Nortis Inc.
• Hesperos, Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Organ-on-Chip Market was valued at USD 467.57 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 25.61% through 2030. Organs-on-chip are sophisticated artificial replicas of human organs. These cutting-edge devices utilize multichannel 3D microfluidic cell culture technology to faithfully mimic organ functions, processes, and physiological responses. By combining labs-on-chips (LOCs) with cell biology, researchers have successfully created a novel model of in vitro multicellular human beings, allowing for the analysis of human physiology within organ-specific environments.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 467.57 Million
Market Size 2030	USD 1804.00 Million
CAGR 2025-2030	25.61%
Fastest Growing Segment	Pharmaceutical & Biotechnology Companies
Largest Market	North America

These chips feature intricately designed microchannels that facilitate blood and air flow, enabling the simulation of various organs such as the lung, intestine, brain, liver, and heart. The microchips are populated with live cells, fostering tissue and organ function through constant perfusion. Organ-on-chip technology, with its unique blend of silicone nourishment, tissue engineering, and microfluidics, has the potential to revolutionize the field. These advancements hold great promise in addressing longstanding challenges in drug discovery and disease treatment, making it a crucial component in drug development investigations and propelling the organ-on-chip industry forward.

Key Market Drivers

Growing Demand of Miniaturization of Electronic Chips

The growing prevalence for microchips in the field of medical devices is a direct result of remarkable technological advancements. These advancements have not only fueled the demand for such devices but also paved the way for significant improvements in their construction and maintenance. The process of miniaturization has played a key role in achieving these advancements, as it allows for the reduction of materials required to build and sustain the system.

Moreover, the utilization of microfluidic chips has revolutionized the development of miniaturized tissues, enabling the simulation of real tissue in organ-on-a-chip systems. By creating an in vitro environment at the microscopic scale, these microfluidic chips effectively mimic the function and structure of actual organs. This breakthrough technology holds tremendous promise in advancing our understanding of organ function and disease progression. The integration of microchips and microfluidic chips in medical devices marks a significant milestone in the field of healthcare. With continued research and innovation, we can expect even greater advancements in this fascinating area, ultimately leading to improved diagnostics, treatments, and overall patient care.

Key Market Challenges

Concerns Pertaining due to High Cost of Organ Chip Device

The high cost associated with the organ chip device, coupled with the fact that organ-on-chip (OOC) technology is still in its early stages, is projected to limit the expansion of the market. This is primarily due to the significant investment required for research and development, manufacturing, and commercialization of organ-on-chip devices. The complex nature of the technology, involving the integration of multiple organ models and microfluidic systems, adds to the manufacturing challenges and cost considerations.

Furthermore, certain countries have imposed restrictions on cosmetic testing on animals, which is likely to further hinder the growth of the global organ-on-chip market. In these countries, the government has prohibited the use of animals for testing cosmetics developed within their borders, reflecting a growing awareness and concern for animal welfare. This shift in regulatory policies has prompted the need for alternative testing methods, such as organ-on-chip technology, which can simulate the physiological conditions of human organs and provide more accurate and ethical results.

These factors collectively contribute to the complex landscape surrounding the adoption and market potential of organ-on-chip technology. While the technology holds great promise for revolutionizing drug discovery, toxicity testing, and personalized medicine, overcoming the barriers of cost, scale-up, and regulatory requirements remains crucial for its widespread adoption and market success. Continued advancements in technology, coupled with collaborative efforts between academia, industry, and regulatory bodies, will play a vital role in addressing these challenges and unlocking the full potential of organ-on-chip technology in improving healthcare outcomes.

Key Market Trends

Increasing Market Developments

The organ-on-chip market is witnessing significant growth largely driven by a series of strategic market developments such as product launches, collaborations, mergers, and acquisitions. Companies in this space are continuously innovating by launching new organ-on-chip devices that more accurately mimic human organs and their functions. These innovations not only improve the reliability and efficiency of the technology but also expand its applications across various fields including drug discovery, toxicology testing, and personalized medicine. As new products emerge, they attract a broader range of customers, which helps drive the overall market expansion.

Collaborations between biotech firms, pharmaceutical companies, and research institutions are playing a crucial role in accelerating the development and commercialization of organ-on-chip technologies. By combining expertise and resources, these partnerships help in speeding up research, validating new models, and entering new markets. Additionally, collaborations often enable sharing of high-cost resources and access to advanced technology platforms, which further promotes innovation and market penetration.

Mergers and acquisitions are also key drivers of growth in the organ-on-chip market. Larger companies are acquiring smaller startups that have developed innovative technologies, allowing them to quickly integrate new capabilities and expand their product portfolios. These consolidations provide companies with enhanced financial and technical resources, enabling more substantial investments in research and marketing. Moreover, such activities help strengthen competitive positioning and broaden the reach of organ-on-chip solutions.

Another important factor fueling market growth is increased funding from venture capital, government grants, and other investors. This influx of capital supports further innovation, clinical validation, and regulatory approval processes, all of which are critical to bringing advanced organ-on-chip products to market. In parallel, regulatory agencies are gradually recognizing the value of organ-on-chip platforms as alternatives to traditional animal testing, which has encouraged adoption by reducing barriers related to compliance and ethical concerns.

Key Market Players

• Altis Biosystems
• AxoSim Inc.
• BiomimX SRL
• Emulate Inc.
• Hesperos
• Allevi Inc.
• InSphero AG
• MIMETAS BV
• Nortis Inc.
• Hesperos, Inc.

Report Scope:

In this report, the Global Organ-on-Chip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ-on-Chip Market, By Type:

• Liver
• Heart
• Lung
• Kidney
• Others

Organ-on-Chip Market, By Offering:

• Products
• Services

Organ-on-Chip Market, By Material Type:

• Polymer
• PDMS
• Glass
• Silicon
• Others

Organ-on-Chip Market, By Application:

• Physiological Model Development
• Drug Discovery
• Toxicological Research
• Molecular Biology
• Others

Organ-on-Chip Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Organ-on-Chip Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ-on-Chip Market.

Available Customizations:

Global Organ-on-Chip market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ-on-Chip Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Liver, Heart, Lung, Kidney, Others)
  • 5.2.2. By Offering (Products v/s Services)
  • 5.2.3. By Material Type (Polymer, PDMS, Glass, Silicon, Others)
  • 5.2.4. By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Organ-on-Chip Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Offering
  • 6.2.3. By Material Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ-on-Chip Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Offering
      • 6.3.1.2.3. By Material Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Organ-on-Chip Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Offering
      • 6.3.2.2.3. By Material Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Organ-on-Chip Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Offering
      • 6.3.3.2.3. By Material Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Organ-on-Chip Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Offering
  • 7.2.3. By Material Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ-on-Chip Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Offering
      • 7.3.1.2.3. By Material Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Organ-on-Chip Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Offering
      • 7.3.2.2.3. By Material Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Organ-on-Chip Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Offering
      • 7.3.3.2.3. By Material Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Organ-on-Chip Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Offering
      • 7.3.4.2.3. By Material Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Organ-on-Chip Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Offering
      • 7.3.5.2.3. By Material Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Organ-on-Chip Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Offering
  • 8.2.3. By Material Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Organ-on-Chip Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Offering
      • 8.3.1.2.3. By Material Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Organ-on-Chip Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Offering
      • 8.3.2.2.3. By Material Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Organ-on-Chip Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Offering
      • 8.3.3.2.3. By Material Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Organ-on-Chip Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Offering
      • 8.3.4.2.3. By Material Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Organ-on-Chip Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Offering
      • 8.3.5.2.3. By Material Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Organ-on-Chip Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Offering
  • 9.2.3. By Material Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ-on-Chip Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Offering
      • 9.3.1.2.3. By Material Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Organ-on-Chip Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Offering
      • 9.3.2.2.3. By Material Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Organ-on-Chip Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Offering
      • 9.3.3.2.3. By Material Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Organ-on-Chip Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Offering
  • 10.2.3. By Material Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ-on-Chip Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Offering
      • 10.3.1.2.3. By Material Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Organ-on-Chip Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Offering
      • 10.3.2.2.3. By Material Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Organ-on-Chip Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Offering
      • 10.3.3.2.3. By Material Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Organ-on-Chip Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Altis Biosystems
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. AxoSim Inc.
• 15.3. BiomimX SRL
• 15.4. Emulate Inc.
• 15.5. Hesperos
• 15.6. Allevi Inc.
• 15.7. InSphero AG
• 15.8. MIMETAS BV
• 15.9. Nortis Inc.
• 15.10. Hesperos, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer